A devastating nerve disease stalks a mountain village

Updated on: December 30,2024

A devastating nerve disease stalks a mountain village

Updated on:December 30,2024

Researchers propose a new treatment for brain metastasis based on immunotherapy

byThe Spanish National Cancer Research CentreCells around a brain metastasis in an animal model: several brain cells (astrocytes, white) surround an immune system cell (lymphocyte, green). Some

Updated on: October 24,2024

Researchers propose a new treatment for brain metastasis based on immunotherapy

byThe Spanish National Cancer Research CentreCells around a brain metastasis in an animal model: several brain cells (astrocytes, white) surround an immune system cell (lymphocyte, green). Some

Updated on:October 24,2024

More pain, more burdens: Researchers find link between chronic pain and dementia

by Chinese Academy of SciencesElevated dementia risk, cognitive decline, and hippocampalatrophy in multisite chronic pain. Credit: Tu YihengA research team led by Dr. Tu Yiheng from the Institute

Updated on: June 05,2024

More pain, more burdens: Researchers find link between chronic pain and dementia

by Chinese Academy of SciencesElevated dementia risk, cognitive decline, and hippocampalatrophy in multisite chronic pain. Credit: Tu YihengA research team led by Dr. Tu Yiheng from the Institute

Updated on:June 05,2024

Faster, stronger … smarter? New research shows the importance of brain training for junior athletes

by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?

Updated on: July 31,2024

Faster, stronger … smarter? New research shows the importance of brain training for junior athletes

by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?

Updated on:July 31,2024

Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

byNagoya UniversityResearchers have discovered a receptor, sigma-1 receptor (green), and a protein, ATAD3A (red), that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou

Updated on: April 09,2024

Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

byNagoya UniversityResearchers have discovered a receptor, sigma-1 receptor (green), and a protein, ATAD3A (red), that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou

Updated on:April 09,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on: June 04,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on:June 04,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on: May 13,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on:May 13,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on: November 07,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on:November 07,2024

Surgical removal beneficial for acute intracerebral hemorrhage

by Elana GotkineFor patients with an acute intracerebral hemorrhage, minimally invasive surgical removal is associated with improved outcomes, according to a study published in the April 11 issue of t

Updated on: April 28,2024

Surgical removal beneficial for acute intracerebral hemorrhage

by Elana GotkineFor patients with an acute intracerebral hemorrhage, minimally invasive surgical removal is associated with improved outcomes, according to a study published in the April 11 issue of t

Updated on:April 28,2024

Team develops app to help train the brain to overcome tinnitus

by MindEarThe MindEar app includes training and education on tinnitus, helping patients better manage symptoms. Credit: MindEarAn international research team has shown that the debilitating impact of

Updated on: January 09,2024

Team develops app to help train the brain to overcome tinnitus

by MindEarThe MindEar app includes training and education on tinnitus, helping patients better manage symptoms. Credit: MindEarAn international research team has shown that the debilitating impact of

Updated on:January 09,2024

People with dementia and financial abuse – the warning signs and how to avoid it

by Clarissa Giebel,The ConversationCredit: AI-generated imageWhen most of us go online to our internet banking account and set up a direct debit to pay a bill, we probably do it swiftly without

Updated on: June 11,2024

People with dementia and financial abuse – the warning signs and how to avoid it

by Clarissa Giebel,The ConversationCredit: AI-generated imageWhen most of us go online to our internet banking account and set up a direct debit to pay a bill, we probably do it swiftly without

Updated on:June 11,2024

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules

Updated on: March 25,2024

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules

Updated on:March 25,2024